Traditional Herbal Medicine Candidates as Complementary Treatments for COVID‐19: A Review of Their Mechanisms, Pros and Cons
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Coronavirus disease 2019 (COVID‐19) is a new infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that belongs to the coronavirus family. The first case was reported in December 2019, and the disease has become a pandemic. Impaired immune regulation is one of the factors that play a role in its pathogenesis and results in poor outcomes of COVID‐19 patients. There have been many studies with drug candidates used as antivirals or immunomodulators. However, the results of these investigations showed that the drug candidates were not significantly effective against the disease. Meanwhile, people believe that consuming herbal immunomodulators can prevent or even cure COVID‐19. Unfortunately, specific preclinical and clinical trials to evaluate the effects of herbal immunoregulators have not been conducted. Certain natural compounds might be effective for the treatment of COVID‐19 based on general concepts from previous experiments. This review discusses some herbal agents extracted from various plants, including Echinacea, Cinchona, Curcuma longa, and Curcuma xanthorrhiza, which are considered for the treatment of COVID‐19. In addition, we discuss the pros and cons of utilising herbal medicine during the COVID‐19 pandemic, draw some conclusions, and make recommendations at the end of the session.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288 · cited 2×
“From this evidence, quinine as a chloroquine analogue might be predicted to have beneficial effects in eliminating the COVID-19 [28].”
BackgroundRetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664 · cited 3×
“In COVID-19, this cytokine storm is characterised by the increase of interleukin (IL)-2, IL-7, granulocyte-colony stimulating factor, IFN-c, inducible protein (IP)-10, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP) 1-α, and tumour necrosis factor (TNF)-α [17].”
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958 · cited 3×
“+is mechanism results in the inhibition of viral infection in vitro [20].”
BackgroundInfluentialA Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187 · cited 1×
“+ese studies also suggested using lopinavir/ritonavir associated with some adverse events, mainly in the gastrointestinal tract [26, 27].”
BackgroundWan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 4×
“respiratory tract, known as the angiotensin-converting enzyme-2 (ACE2) receptor [6].”
BackgroundInfluentialCoronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787 · cited 7×
“+e other is to expose the fusion peptide or cleave at S2 [12].”
BackgroundInfluentialWang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., Fu, S., Gao, L., Cheng, Z., Lu, Q., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31022-9 · Cited by 3,440
Robbins and Cotran Pathologic Basis of Disease
Hoda, S. A., & Hoda, R. S. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa163 · Cited by 3,365
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911 · cited 2×
“Curcumin activates the same mechanism when it is administered as an ACE inhibitor [42, 44, 45].”
BackgroundCurcumin: A Review of Its Effects on Human Health
Hewlings, S., & Kalman, D. (2017) · Foods · doi:10.3390/foods6100092 · Cited by 2,720 · cited 3×
“+is medicine serves as an antioxidant, anti-inflammatory, anticancer agent and is used in the treatment for many other diseases, such as diabetes mellitus, cardiovascular disease, obesity, neurodegenerative disease, inflammatory bowel disease, allergy or asthma, and psoriasis [9, 38].”
BackgroundAdhikari, S. P., Meng, S., Wu, Y.-J., Mao, Y.-P., Ye, R.-X., Wang, Q.-Z., Sun, C., Sylvia, S., Rozelle, S., Raat, H., et al. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00646-x · Cited by 2,402 · cited 1×
“Furthermore, there are two other ways of transmitting the virus, including contact and aerosol transmission [4].”
BackgroundInterferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160 · cited 1×
“+e RNase L pathway can eliminate ssRNA in virusinfected cells, while PKR blocks the translation and affect signal transduction [59].”
BackgroundRenin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
Coronavirus Disease 2019 (COVID-19): A Perspective from China
Zu, Z. Y., Jiang, M. D., Xu, P. P., Chen, W., Ni, Q. Q., Lu, G. M., & Zhang, L. J. (2020) · Radiology · doi:10.1148/radiol.2020200490 · Cited by 2,070 · cited 5×
“After the S protein of the virus binds with ACE2, the virus envelope can fuse with the host cell membrane and enter the host cell [6, 10].”
BackgroundInfluentialInto the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · cited 1×
“TNFα is a central cytokine that plays an important role in local tissue inflammation, such as an increase in vascular permeability, adhesion, and migration of leukocytes and secretion of other cytokines including IL-1 and IL-6 by activated leukocytes [35, 36].”
BackgroundChloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811
Shimabukuro-Vornhagen, A., Gödel, P., Subklewe, M., Stemmler, H. J., Schlößer, H. A., Schlaak, M., Kochanek, M., Böll, B., & von Bergwelt-Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,656 · cited 1×
“However, if this vicious circle continuously happens, CRS may lead to a life-threatening condition, including shock and the necessity of mechanical ventilation [37].”
BackgroundImmune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0772 · Cited by 1,537 · cited 5×
“+is IFN and its downstream effects might regulate replication of the virus and induction of the adaptive immune response [14].”
BackgroundInfluentialPotential interventions for novel coronavirus in China: A systematic review
Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,348 · cited 1×
“Since the immune status of patients plays an essential role in COVID-19 infection, an herbal medicine, which has an immunomodulatory effect, could have potential as a preventive measure and even therapeutic agent for patients with COVID-19 infection [7, 8].”
BackgroundDefining the Epidemiology of Covid-19 — Studies Needed
Lipsitch, M., Swerdlow, D. L., & Finelli, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2002125 · Cited by 1,248 · cited 2×
“+e current pandemic of COVID-19 that is spreading across countries originated inWuhan, China [1].”
BackgroundCurcumin, an active component of turmeric (Curcuma longa), and its effects on health
Kocaadam, B., & Şanlier, N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1077195 · Cited by 1,207 · cited 5×
“+e treatment with turmeric has been investigated in preclinical and clinical studies [9, 38].”
BackgroundInfluentialComparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Petersen, E., Koopmans, M., Go, U., Hamer, D. H., Petrosillo, N., Castelli, F., Storgaard, M., Al Khalili, S., & Simonsen, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30484-9 · Cited by 1,205
Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China
Deng, S.-Q., & Peng, H.-J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020575 · Cited by 718 · cited 9×
“SARS-CoV and the Middle East respiratory syndrome coronavirus (MERS-CoV) are coronaviruses that infect humans.”
BackgroundInfluentialThe cytokine storm of severe influenza and development of immunomodulatory therapy
Liu, Q., Zhou, Y.-H., & Yang, Z.-Q. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.74 · Cited by 716 · cited 2×
“+is condition happens after infection with some influenza viruses [16].”
BackgroundDhama, K., Sharun, K., Tiwari, R., Dadar, M., Malik, Y. S., Singh, K. P., & Chaicumpa, W. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1735227 · Cited by 623 · cited 2×
“Current preventive and treatment efforts for COVID-19 have focused developing vaccines and specific therapeutic agents targeting SARS-CoV-2 [18].”
BackgroundMethodBarnes, J., Anderson, L. A., Gibbons, S., & Phillipson, J. D. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357056127 · Cited by 424 · cited 1×
“It contains several bioactive compounds like chicoric acid and caffeic acids, alkylamides, and polysaccharides [33].”
BackgroundLi, Y., Xie, Z., Lin, W., Cai, W., Wen, C., Guan, Y., Mo, X., Wang, J., Wang, Y., Peng, P., et al. (2020) · Med · doi:10.1016/j.medj.2020.04.001 · Cited by 385
Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review
Rajendran, K., Krishnasamy, N., Rangarajan, J., Rathinam, J., Natarajan, M., & Ramachandran, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25961 · Cited by 360 · cited 1×
“+ere has not been a high-quality randomized controlled trial to establish the efficacy and safety [31].”
BackgroundSARS-CoV-2: virus dynamics and host response
Chen, Y., & Li, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30235-8 · Cited by 286 · cited 1×
“+en, IgM and IgG begin to increase on day 10 [15].”
BackgroundImmunomodulators Inspired by Nature: A Review on Curcumin and Echinacea
Catanzaro, M., Corsini, E., Rosini, M., Racchi, M., & Lanni, C. (2018) · Molecules · doi:10.3390/molecules23112778 · Cited by 258 · cited 12×
“Otherwise, quinine inhibits the release of TNF-α and has an immunosuppressant effect.”
BackgroundResultInfluentialSingh, A. K., Majumdar, S., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.054 · Cited by 252 · cited 1×
“Nevertheless, to confirm the reliability, a multicentre study is necessary [30].”
BackgroundDoes SARS‐CoV‐2 has a longer incubation period than SARS and MERS?
Jiang, X., Rayner, S., & Luo, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25708 · Cited by 244 · cited 1×
“5%, respectively, with a known bat coronavirus and SARS-CoV [12, 13].”
BackgroundEchinacea-induced cytokine production by human macrophages
Burger, R. A., Torres, A. R., Warren, R. P., Caldwell, V. D., & Hughes, B. G. (1997) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(97)00061-1 · Cited by 231 · cited 1×
“+ey demonstrated that echinacea mediated the increased release of various cytokines, including IL-1, IL-10, and TNF-α by macrophages [34].”
BackgroundImmunomodulatory and therapeutic activity of curcumin
Srivastava, R. M., Singh, S., Dubey, S. K., Misra, K., & Khar, A. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.014 · Cited by 215 · cited 12×
“Otherwise, quinine inhibits the release of TNF-α and has an immunosuppressant effect.”
ResultInfluentialXanthorrhizol: a review of its pharmacological activities and anticancer properties
Oon, S. F., Nallappan, M., Tee, T. T., Shohaimi, S., Kassim, N. K., Fazry, S., & Cheah, Y. H. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0255-4 · Cited by 188 · cited 1×
“It also has been used as a food additive to enhance the flavour of food [63].”
MethodSharma, M., Anderson, S. A., Schoop, R., & Hudson, J. B. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.04.009 · Cited by 179 · cited 4×
“Many Native Americans use this kind of herb for respiratory infections [8, 32].”
BackgroundInfluentialThe Use of Antimalarial Drugs against Viral Infection
D’Alessandro, S., Scaccabarozzi, D., Signorini, L., Perego, F., Ilboudo, D. P., Ferrante, P., & Delbue, S. (2020) · Microorganisms · doi:10.3390/microorganisms8010085 · Cited by 174
Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
Rinninella, E., Cintoni, M., Raoul, P. C., Ianiro, G., Laterza, L., Lopetuso, L. R., Ponziani, F. R., Gasbarrini, A., & Mele, M. C. (2020) · Microorganisms · doi:10.3390/microorganisms8081140 · Cited by 157
Lim, C. S., Jin, D., Mok, H., Oh, S. J., Lee, J. U., Hwang, J. K., Ha, I., & Han, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20692 · Cited by 139
Kim, M., Kim, C., Song, Y., & Hwang, J. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/205915 · Cited by 117
Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases
Shimizu, K., Funamoto, M., Sunagawa, Y., Shimizu, S., Katanasaka, Y., Miyazaki, Y., Wada, H., Hasegawa, K., & Morimoto, T. (2019) · European Cardiology Review · doi:10.15420/ecr.2019.17.2 · Cited by 106 · cited 1×
“Some studies showed that the antiinflammatory effect of curcumin via inhibition on the tolllike receptor (TLR-4), phosphatidylinositol-3 kinase (PI3K), nuclear factor-kappa B (NF-κB), and others resulted in decreased production of IL-6, tumour necrosis factor (TNFα), and interleukin (IL-1β), which are proinflammatory…”
BackgroundNewborn screening as we move to the twenty-first century.
Kidson, C. (1999) · PubMed · Cited by 93
The effect of Curcumin/Turmeric on blood pressure modulation: A systematic review and meta-analysis
Hadi, A., Pourmasoumi, M., Ghaedi, E., & Sahebkar, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104505 · Cited by 93
Lekshmi, P. C., Arimboor, R., Nisha, V. M., Menon, A. N., & Raghu, K. G. (2013) · Journal of Food Science and Technology · doi:10.1007/s13197-013-0953-7 · Cited by 90 · cited 1×
“that curcumin could be used as a treatment for hypertension [39, 40].”
BackgroundEchinacea—A Source of Potent Antivirals for Respiratory Virus Infections
Hudson, J. B., & Vimalanathan, S. (2011) · Pharmaceuticals · doi:10.3390/ph4071019 · Cited by 86 · cited 1×
“Many Native Americans use this kind of herb for respiratory infections [8, 32].”
BackgroundCortegiani, A., Ippolito, M., Ingoglia, G., Iozzo, P., Giarratano, A., & Einav, S. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.06.019 · Cited by 81 · cited 1×
“Furthermore, the combination of chloroquine/hydroxychloroquine and macrolide showed a harmful event during treatment and might not reduce the rate of COVID-19 infection [29].”
BackgroundDrug repurposing of quinine as antiviral against dengue virus infection
Malakar, S., Sreelatha, L., Dechtawewat, T., Noisakran, S., Yenchitsomanus, P., Chu, J. J. H., & Limjindaporn, T. (2018) · Virus Research · doi:10.1016/j.virusres.2018.07.018 · Cited by 79 · cited 2×
“As the relative similarity of dengue virus and SARS-CoV-2 structures, it may be possible that SARS-CoV-2 uses some relative methods to infect the cell and trigger cytokines to combating the virus (Figure 4) [57].”
BackgroundAkinyemi, A. J., Adedara, I. A., Thome, G. R., Morsch, V. M., Rovani, M. T., Mujica, L. K. S., Duarte, T., Duarte, M., Oboh, G., & Schetinger, M. R. C. (2015) · Toxicology Reports · doi:10.1016/j.toxrep.2015.10.001 · Cited by 75 · cited 1×
“Curcumin activates the same mechanism when it is administered as an ACE inhibitor [42, 44, 45].”
BackgroundRemdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
Davies, M., Osborne, V., Lane, S., Roy, D., Dhanda, S., Evans, A., & Shakir, S. (2020) · Drug Safety · doi:10.1007/s40264-020-00952-1 · Cited by 69 · cited 1×
“+ere is still a need for benefit and safety data for remdesivir to provide further studies [21].”
BackgroundACE and ACE2: a tale of two enzymes
Zisman, L. S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi043 · Cited by 60 · cited 1×
“An investigation in 2005 showed that ACE2 was not inhibited by the administration of ACE inhibitors in hypertensive patients [46].”
BackgroundDiversity and severity of adverse reactions to quinine: A systematic review
Liles, N. W., Page, E. E., Liles, A., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24314 · Cited by 56 · cited 1×
“+e documented damage involves organ systems including haematologic manifestations: thrombocytopenia and haemolytic anaemia; dermatologic manifestations: photosensitive eczema; systemic reactions: hypotension and anaphylaxis; cardiac manifestations: chest pain and pericarditis; liver toxicity: elevated serum transamina…”
BackgroundLopinavir/ritonavir for COVID-19: A living systematic review
Verdugo‐Paiva, F., Izcovich, A., Ragusa, M. A., & Gabriel Rada, G. (2020) · Medwave · doi:10.5867/medwave.2020.06.7966 · Cited by 54
Maldonado, C., Barnes, C. J., Cornett, C., Holmfred, E., Hansen, S. H., Persson, C., Antonelli, A., & Rønsted, N. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00391 · Cited by 48 · cited 1×
“+is beneficial effect was first discovered by Jesuit missionaries and gradually expanded throughout the world [51].”
BackgroundQuinine Inhibits Production of Tumor Necrosis Factor-α from Human Alveolar Macrophages
Maruyama, N., Kakuta, Y., Yamauchi, K., Ohkawara, Y., Aizawa, T., Ohrui, T., Nara, M., Oshiro, T., Ohno, I., & Tamura, G. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.5.8179913 · Cited by 42 · cited 2×
“Because quinine blocks the expression of TNF-α at the mRNA transcription level, analysed by northern blot, it will alleviate an inflammatory reaction in microbe-infected individuals rather than promoting the process of inflammation [60].”
BackgroundVeljković, V., Vergara‐Alert, J., Segalés, J., & Paessler, S. (2020) · F1000Research · doi:10.12688/f1000research.22149.4 · Cited by 39 · cited 1×
“Some experimental studies have shown that giving the full-length S protein may induce the release of a protective antibody by blocking the binding of the virus with the ACE2 receptor [19].”
Baroni, A., Paoletti, I., Ruocco, E., Ayala, F., Corrado, F., Wolf, R., Tufano, M. A., & Donnarumma, G. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.009 · Cited by 37 · cited 1×
“in their report that evaluated quinine sulphate onHSV-1HaCat cells infected, which suggested that quinine acts to inhibit the viral infection through indirect pathways, such as activating the protein heat shock response, interfering with multiple pathways during virus replication, and inhibiting NF-kB by blocking the…”
BackgroundWahono, C. S., Setyorini, C. D., Kalim, H., Nurdiana, N., & Handono, K. (2017) · International Journal of Rheumatology · doi:10.1155/2017/7687053 · Cited by 36
Abolghasemi, E., Moosa‐Kazemi, S. H., Davoudi, M., Reisi, A., & Satvat, M. T. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60030-6 · Cited by 35 · cited 1×
“+us, it is known as a chloroquine analogue [52].”
BackgroundAlhenc‐Gelas, F., Bouby, N., & Girolami, J. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00136 · Cited by 30 · cited 1×
“Curcumin activates the same mechanism when it is administered as an ACE inhibitor [42, 44, 45].”
BackgroundThe Spice For Hypertension: Protective Role of Curcuma Longa
Leong, X.-F. (2018) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1555 · Cited by 18
Yao, Y., Wang, W., Li, M., Ren, H., Chen, C., Wang, J., Wang, W. E., Yang, J., & Zeng, C. (2016) · Scientific Reports · doi:10.1038/srep25579 · cited 1×
“Blocking the binding process resulted in the inability of the blood vessel to constrict, a decrease in renal and another tissue perfusion, and resulted in a reduction in blood pressure (Figure 3) [43].”
Background
Cited by
Traditional Chinese medicine in COVID-19
Lyu, M., Fan, G., Xiao, G., Wang, T., Xu, D., Gao, J., Ge, S., Li, Q., Ma, Y., Zhang, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.008 · Cited by 224
Metadata
- Authors
- Nugraha, R. V., Ridwansyah, H., Ghozali, M., Khairani, A. F., & Atik, N.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2020-01
- Volume
- 2020
- Issue
- 1
- Pages
- 2560645-2560645
- ISSN
- 1741-427X (ISSN-L)
- 1741-4288
- OpenAlex
- W3092490057
- Cited by
- 233
- References
- 62
- FWCI
- 26.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.